Hypoxia induces p53 through a pathway distinct from most DNA-damaging and stress-inducing agents

The p53 tumour suppressor gene is a transcription factor that can induce cell cycle arrest and apoptosis. In response to various stress-inducing signals, p53 level increases and this is accompanied with increased activities of p53. Interestingly, the methylxanthine caffeine can abrogate the p53 accu...

Full description

Saved in:
Bibliographic Details
Published inCarcinogenesis (New York) Vol. 24; no. 7; pp. 1177 - 1182
Main Authors Renton, Alan, Llanos, Susana, Lu, Xin
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 01.07.2003
Oxford Publishing Limited (England)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The p53 tumour suppressor gene is a transcription factor that can induce cell cycle arrest and apoptosis. In response to various stress-inducing signals, p53 level increases and this is accompanied with increased activities of p53. Interestingly, the methylxanthine caffeine can abrogate the p53 accumulation induced by certain DNA-damaging agents by an unknown mechanism. In an effort to understand how different signals induce p53, human tumour cell lines were treated with combinations of various stress-inducing agents and caffeine. Caffeine inhibited the accumulation of p53 induced by leptomycin B (LMB), an inhibitor of CRM1, but not N-acetyl-leu-leu-norleucinal, a proteasome inhibitor. Furthermore, caffeine also inhibited the accumulation of p53 by a variety of stress-inducing agents in vivo, such as 5-fluorouracil, doxorubicin, mitomycin C, camptothecin and roscovitine. However, caffeine failed to affect the accumulation of p53 in hypoxia (HYP)-treated cells. These results suggested that HYP must use a distinct pathway from most DNA-damaging and stress-inducing agents to induce p53.
Bibliography:istex:0A6AD4BF90C162654390FA7AC8FBA46255B2EF42
local:bgg044
1To whom correspondence should be addressed Email: x.lu@ic.ac.uk
ark:/67375/HXZ-FVPV27PD-P
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0143-3334
1460-2180
DOI:10.1093/carcin/bgg044